180 related articles for article (PubMed ID: 8501150)
21. Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study.
Brixen K; Kassem M; Nielsen HK; Loft AG; Flyvbjerg A; Mosekilde L
J Bone Miner Res; 1995 Dec; 10(12):1865-74. PubMed ID: 8619366
[TBL] [Abstract][Full Text] [Related]
22. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
Kassem M; Brixen K; Blum WF; Mosekilde L; Eriksen EF
J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819
[TBL] [Abstract][Full Text] [Related]
23. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
[TBL] [Abstract][Full Text] [Related]
24. Parathyroid hormone may maintain bone formation in hibernating black bears (Ursus americanus) to prevent disuse osteoporosis.
Donahue SW; Galley SA; Vaughan MR; Patterson-Buckendahl P; Demers LM; Vance JL; McGee ME
J Exp Biol; 2006 May; 209(Pt 9):1630-8. PubMed ID: 16621944
[TBL] [Abstract][Full Text] [Related]
25. Long-term treatment of acromegaly with lanreotide: evidence of increased serum parathormone concentration.
Cappelli C; Gandossi E; Agosti B; Cerudelli B; Cumetti D; Castellano M; Pirola I; De Martino E; Rosei EA
Endocr J; 2004 Dec; 51(6):517-20. PubMed ID: 15644568
[TBL] [Abstract][Full Text] [Related]
26. Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria?
Kamenický P; Blanchard A; Gauci C; Salenave S; Letierce A; Lombès M; Brailly-Tabard S; Azizi M; Prié D; Souberbielle JC; Chanson P
J Clin Endocrinol Metab; 2012 Jun; 97(6):2124-33. PubMed ID: 22496496
[TBL] [Abstract][Full Text] [Related]
27. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD
Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
[TBL] [Abstract][Full Text] [Related]
29. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
Murphy MG; Bach MA; Plotkin D; Bolognese J; Ng J; Krupa D; Cerchio K; Gertz BJ
J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
[TBL] [Abstract][Full Text] [Related]
30. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
[TBL] [Abstract][Full Text] [Related]
31. Differential presentation of cortical and trabecular peripheral bone mineral density in acromegaly.
Jockenhövel F; Rohrbach S; Deggerich S; Reinwein D; Reiners C
Eur J Med Res; 1996 May; 1(8):377-82. PubMed ID: 9360937
[TBL] [Abstract][Full Text] [Related]
32. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
[TBL] [Abstract][Full Text] [Related]
33. Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly.
Ueland T; Ebbesen EN; Thomsen JS; Mosekilde L; Brixen K; Flyvbjerg A; Bollerslev J
Eur J Clin Invest; 2002 Feb; 32(2):122-8. PubMed ID: 11895459
[TBL] [Abstract][Full Text] [Related]
34. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
Janssen YJ; Hamdy NA; Frölich M; Roelfsema F
J Clin Endocrinol Metab; 1998 Jun; 83(6):2143-8. PubMed ID: 9626153
[TBL] [Abstract][Full Text] [Related]
35. Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy.
Takamoto S; Tsuchiya H; Onishi T; Morimoto S; Imanaka S; Mori S; Seino Y; Uozumi T; Kumahara Y
J Clin Endocrinol Metab; 1985 Jul; 61(1):7-11. PubMed ID: 3839000
[TBL] [Abstract][Full Text] [Related]
36. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa.
Hotta M; Fukuda I; Sato K; Hizuka N; Shibasaki T; Takano K
J Clin Endocrinol Metab; 2000 Jan; 85(1):200-6. PubMed ID: 10634387
[TBL] [Abstract][Full Text] [Related]
37. Lack of insulin-like growth factor I exaggerates the effect of calcium deficiency on bone accretion in mice.
Kasukawa Y; Baylink DJ; Wergedal JE; Amaar Y; Srivastava AK; Guo R; Mohan S
Endocrinology; 2003 Nov; 144(11):4682-9. PubMed ID: 12960002
[TBL] [Abstract][Full Text] [Related]
38. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
[TBL] [Abstract][Full Text] [Related]
39. Effects of rhIGF-I administration on bone turnover during short-term fasting.
Grinspoon SK; Baum HB; Peterson S; Klibanski A
J Clin Invest; 1995 Aug; 96(2):900-6. PubMed ID: 7543494
[TBL] [Abstract][Full Text] [Related]
40. Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly.
Fukuoka H; Takahashi Y; Iida K; Kudo T; Nishizawa H; Imanaka M; Takeno R; Iguchi G; Takahashi K; Okimura Y; Kaji H; Chihara K
Horm Res; 2008; 69(3):165-71. PubMed ID: 18219220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
